The mean cumulative risk of having ovarian cancer with BRCA1 pathogenic mutation is 40% [95% confidence interval (CI): 35–46%], and 18% (95% CI: 13–23%) for patients carrying BRCA2 mutations. This evidence concerns the gene BRCA1 and ovarian carcinoma.